Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy
Michael R. Shurin, Viktor Umansky
Journal of Clinical Investigation (2022) Vol. 132, Iss. 9
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
Qian Li, Jingjing Han, Yonglin Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 112
Hypoxia signaling in cancer: Implications for therapeutic interventions
Yan Zhuang, Kua Liu, Qinyu He, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 57
Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
Yuqing Ren, Ruizhi Wang, Siyuan Weng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 50
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression
Yaojie Fu, Bryan Mackowiak, Dechun Feng, et al.
Gut (2023) Vol. 72, Iss. 10, pp. 1942-1958
Open Access | Times Cited: 41
Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy
Jing Yang, Bibo Ren, Xuntao Yin, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 29
Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 25
Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer
Corey Dussold, Kaylee Zilinger, Jillyn Turunen, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 17
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Yi Shi, Daniele M. Gilkes
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 3
Alleviating hypoxia to improve cancer immunotherapy
Peng Fan, Naidong Zhang, Eleonora Candi, et al.
Oncogene (2023) Vol. 42, Iss. 49, pp. 3591-3604
Closed Access | Times Cited: 31
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma
Charles B. Nguyen, Eugene Oh, Piroz Bahar, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 601-601
Open Access | Times Cited: 10
Adjuvant Properties of Caffeic Acid in Cancer Treatment
Nicole Cortez, Cecilia Villegas, Viviana Burgos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7631-7631
Open Access | Times Cited: 10
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer
Xingyu Chen, Lixiang Feng, Yujing Huang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 104-104
Open Access | Times Cited: 37
The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions
Tianqi Zhang, Qianyu Lv, Weilin Jin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189137-189137
Closed Access | Times Cited: 7
Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion
Fei Li, Y J Wang, Dandan Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1396-1396
Open Access | Times Cited: 6
Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma
Song‐Yang Yu, Sheng Su, Peng‐Cheng Wang, et al.
Cancer Letters (2024) Vol. 591, pp. 216872-216872
Closed Access | Times Cited: 6
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review
Huilan Zheng, Gang Wang, Ming Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy
Seyed Mohammadmahdi Meybodi, Mahsa Ejlalidiz, Mohammadsadegh Rezaeian Manshadi, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104340-104340
Open Access | Times Cited: 5
The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
Chengyuan Li, Yucheng Xue, Eloy Yinwang, et al.
Cancer Reports (2025) Vol. 8, Iss. 2
Open Access
Characterization of Exhausted T Cell Signatures in Pan-Cancer Settings
Rifat Tasnim Juthi, Saiful Arefeen Sazed, Manvita Mareboina, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2311-2311
Open Access
High-Sensitivity PD-L1 Staining Using Clone 73-10 Antibody and Spatial Transcriptomics for Precise Expression Analysis in Non-Tumorous, Intraepithelial neoplasia, and Squamous Cell Carcinoma of Head and Neck
Yuri Noda, Naho Atsumi, Takeo Nakaya, et al.
Research Square (Research Square) (2025)
Closed Access
Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages
Zhilei Cui, Zhengshang Ruan, Meigui Li, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110652-110652
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top